nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—PTGS1—Ifosfamide—germ cell cancer	0.224	0.319	CbGbCtD
Diflunisal—PTGS2—Cisplatin—germ cell cancer	0.129	0.184	CbGbCtD
Diflunisal—PTGS2—Etoposide—germ cell cancer	0.127	0.181	CbGbCtD
Diflunisal—PTGS1—Etoposide—germ cell cancer	0.107	0.153	CbGbCtD
Diflunisal—SLC22A6—Methotrexate—germ cell cancer	0.0621	0.0884	CbGbCtD
Diflunisal—ALB—Methotrexate—germ cell cancer	0.0529	0.0753	CbGbCtD
Diflunisal—TTR—choroid plexus—germ cell cancer	0.0348	0.258	CbGeAlD
Diflunisal—TTR—urine—germ cell cancer	0.00932	0.069	CbGeAlD
Diflunisal—TTR—pineal body—germ cell cancer	0.00886	0.0656	CbGeAlD
Diflunisal—Peptic ulcer—Vinblastine—germ cell cancer	0.00378	0.0233	CcSEcCtD
Diflunisal—TTR—neck—germ cell cancer	0.00361	0.0268	CbGeAlD
Diflunisal—UGT1A8—endocrine gland—germ cell cancer	0.00337	0.0249	CbGeAlD
Diflunisal—UGT1A8—head—germ cell cancer	0.00332	0.0246	CbGeAlD
Diflunisal—PTGS2—appendage—germ cell cancer	0.00316	0.0234	CbGeAlD
Diflunisal—TTR—trigeminal ganglion—germ cell cancer	0.00312	0.0231	CbGeAlD
Diflunisal—TTR—embryo—germ cell cancer	0.00301	0.0223	CbGeAlD
Diflunisal—TTR—brainstem—germ cell cancer	0.00276	0.0205	CbGeAlD
Diflunisal—Allergic cutaneous angiitis—Methotrexate—germ cell cancer	0.00271	0.0167	CcSEcCtD
Diflunisal—TTR—eye—germ cell cancer	0.00269	0.0199	CbGeAlD
Diflunisal—TTR—retina—germ cell cancer	0.00266	0.0197	CbGeAlD
Diflunisal—PTGS2—skin epidermis—germ cell cancer	0.00262	0.0194	CbGeAlD
Diflunisal—TTR—telencephalon—germ cell cancer	0.00245	0.0181	CbGeAlD
Diflunisal—Cholestasis—Ifosfamide—germ cell cancer	0.0024	0.0148	CcSEcCtD
Diflunisal—Tubulointerstitial nephritis—Ifosfamide—germ cell cancer	0.00238	0.0147	CcSEcCtD
Diflunisal—PTGS1—ganglion—germ cell cancer	0.00231	0.0171	CbGeAlD
Diflunisal—Proteinuria—Ifosfamide—germ cell cancer	0.00208	0.0128	CcSEcCtD
Diflunisal—Deafness—Vinblastine—germ cell cancer	0.00205	0.0126	CcSEcCtD
Diflunisal—Protein urine present—Ifosfamide—germ cell cancer	0.00205	0.0126	CcSEcCtD
Diflunisal—TTR—pituitary gland—germ cell cancer	0.002	0.0148	CbGeAlD
Diflunisal—PTGS1—endothelium—germ cell cancer	0.00199	0.0148	CbGeAlD
Diflunisal—TTR—medulla oblongata—germ cell cancer	0.00193	0.0143	CbGeAlD
Diflunisal—Hearing impaired—Ifosfamide—germ cell cancer	0.00192	0.0118	CcSEcCtD
Diflunisal—PTGS2—endothelium—germ cell cancer	0.0019	0.0141	CbGeAlD
Diflunisal—PTGS1—blood vessel—germ cell cancer	0.00184	0.0136	CbGeAlD
Diflunisal—TTR—midbrain—germ cell cancer	0.00176	0.013	CbGeAlD
Diflunisal—Leukocytoclastic vasculitis—Methotrexate—germ cell cancer	0.00176	0.0108	CcSEcCtD
Diflunisal—PTGS2—blood vessel—germ cell cancer	0.00176	0.013	CbGeAlD
Diflunisal—Disorientation—Bleomycin—germ cell cancer	0.00173	0.0107	CcSEcCtD
Diflunisal—TTR—bone marrow—germ cell cancer	0.00172	0.0128	CbGeAlD
Diflunisal—TTR—spinal cord—germ cell cancer	0.00172	0.0127	CbGeAlD
Diflunisal—Hearing impaired—Cisplatin—germ cell cancer	0.00165	0.0102	CcSEcCtD
Diflunisal—TTR—endocrine gland—germ cell cancer	0.00155	0.0114	CbGeAlD
Diflunisal—TTR—head—germ cell cancer	0.00153	0.0113	CbGeAlD
Diflunisal—Disorientation—Ifosfamide—germ cell cancer	0.00148	0.00911	CcSEcCtD
Diflunisal—Deafness—Ifosfamide—germ cell cancer	0.00148	0.00911	CcSEcCtD
Diflunisal—TTR—testis—germ cell cancer	0.00147	0.0109	CbGeAlD
Diflunisal—Haemolytic anaemia—Ifosfamide—germ cell cancer	0.00147	0.00902	CcSEcCtD
Diflunisal—Renal impairment—Ifosfamide—germ cell cancer	0.00139	0.00856	CcSEcCtD
Diflunisal—TTR—cerebellum—germ cell cancer	0.00136	0.0101	CbGeAlD
Diflunisal—Gastrointestinal haemorrhage—Ifosfamide—germ cell cancer	0.00132	0.00815	CcSEcCtD
Diflunisal—Agranulocytosis—Vinblastine—germ cell cancer	0.00132	0.00812	CcSEcCtD
Diflunisal—Bronchospasm—Bleomycin—germ cell cancer	0.00132	0.0081	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Dactinomycin—germ cell cancer	0.0013	0.00801	CcSEcCtD
Diflunisal—Deafness—Cisplatin—germ cell cancer	0.00128	0.00785	CcSEcCtD
Diflunisal—Haemolytic anaemia—Cisplatin—germ cell cancer	0.00126	0.00778	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Ifosfamide—germ cell cancer	0.00119	0.00734	CcSEcCtD
Diflunisal—Stomatitis—Bleomycin—germ cell cancer	0.00116	0.00716	CcSEcCtD
Diflunisal—Gastrointestinal haemorrhage—Cisplatin—germ cell cancer	0.00114	0.00702	CcSEcCtD
Diflunisal—Haematuria—Bleomycin—germ cell cancer	0.00114	0.007	CcSEcCtD
Diflunisal—ALB—adrenal gland—germ cell cancer	0.00114	0.00843	CbGeAlD
Diflunisal—SLC22A6—brain—germ cell cancer	0.00113	0.00839	CbGeAlD
Diflunisal—Bronchospasm—Ifosfamide—germ cell cancer	0.00113	0.00693	CcSEcCtD
Diflunisal—TTR—brain—germ cell cancer	0.00111	0.00819	CbGeAlD
Diflunisal—Stevens-Johnson syndrome—Dactinomycin—germ cell cancer	0.0011	0.00679	CcSEcCtD
Diflunisal—Stomatitis—Dactinomycin—germ cell cancer	0.00109	0.00668	CcSEcCtD
Diflunisal—PTGS2—trigeminal ganglion—germ cell cancer	0.00109	0.00803	CbGeAlD
Diflunisal—Dysuria—Ifosfamide—germ cell cancer	0.00107	0.00658	CcSEcCtD
Diflunisal—PTGS2—embryo—germ cell cancer	0.00105	0.00776	CbGeAlD
Diflunisal—Agranulocytosis—Dactinomycin—germ cell cancer	0.00104	0.00639	CcSEcCtD
Diflunisal—Cramp muscle—Cisplatin—germ cell cancer	0.00103	0.00632	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Ifosfamide—germ cell cancer	0.00101	0.00622	CcSEcCtD
Diflunisal—Renal failure—Ifosfamide—germ cell cancer	0.001	0.00617	CcSEcCtD
Diflunisal—Hepatitis—Dactinomycin—germ cell cancer	0.001	0.00615	CcSEcCtD
Diflunisal—Flushing—Bleomycin—germ cell cancer	0.000995	0.00612	CcSEcCtD
Diflunisal—Stomatitis—Ifosfamide—germ cell cancer	0.000995	0.00612	CcSEcCtD
Diflunisal—Vertigo—Vinblastine—germ cell cancer	0.000992	0.00611	CcSEcCtD
Diflunisal—Proteinuria—Methotrexate—germ cell cancer	0.000982	0.00604	CcSEcCtD
Diflunisal—Haematuria—Ifosfamide—germ cell cancer	0.000973	0.00599	CcSEcCtD
Diflunisal—Protein urine present—Methotrexate—germ cell cancer	0.000969	0.00596	CcSEcCtD
Diflunisal—Agranulocytosis—Ifosfamide—germ cell cancer	0.000952	0.00586	CcSEcCtD
Diflunisal—Erythema multiforme—Dactinomycin—germ cell cancer	0.000945	0.00582	CcSEcCtD
Diflunisal—Cramp muscle—Etoposide—germ cell cancer	0.000942	0.00579	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Etoposide—germ cell cancer	0.000942	0.00579	CcSEcCtD
Diflunisal—ALB—testis—germ cell cancer	0.000941	0.00697	CbGeAlD
Diflunisal—Flushing—Dactinomycin—germ cell cancer	0.000928	0.00571	CcSEcCtD
Diflunisal—Hepatitis—Ifosfamide—germ cell cancer	0.000916	0.00564	CcSEcCtD
Diflunisal—Hallucination—Ifosfamide—germ cell cancer	0.000911	0.00561	CcSEcCtD
Diflunisal—PTGS1—telencephalon—germ cell cancer	0.000891	0.0066	CbGeAlD
Diflunisal—Bronchospasm—Etoposide—germ cell cancer	0.000889	0.00547	CcSEcCtD
Diflunisal—Thrombocytopenia—Vinblastine—germ cell cancer	0.000883	0.00543	CcSEcCtD
Diflunisal—Visual impairment—Ifosfamide—germ cell cancer	0.000883	0.00543	CcSEcCtD
Diflunisal—Erythema multiforme—Ifosfamide—germ cell cancer	0.000866	0.00533	CcSEcCtD
Diflunisal—Renal failure—Cisplatin—germ cell cancer	0.000865	0.00532	CcSEcCtD
Diflunisal—Anorexia—Vinblastine—germ cell cancer	0.000859	0.00529	CcSEcCtD
Diflunisal—Stomatitis—Cisplatin—germ cell cancer	0.000857	0.00528	CcSEcCtD
Diflunisal—Tinnitus—Ifosfamide—germ cell cancer	0.000854	0.00525	CcSEcCtD
Diflunisal—PTGS2—telencephalon—germ cell cancer	0.000852	0.00631	CbGeAlD
Diflunisal—PTGS1—skin of body—germ cell cancer	0.000851	0.0063	CbGeAlD
Diflunisal—Flushing—Ifosfamide—germ cell cancer	0.00085	0.00523	CcSEcCtD
Diflunisal—PTGS2—skin of body—germ cell cancer	0.000813	0.00602	CbGeAlD
Diflunisal—Paraesthesia—Vinblastine—germ cell cancer	0.00081	0.00498	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.000799	0.00492	CcSEcCtD
Diflunisal—Chest pain—Bleomycin—germ cell cancer	0.000794	0.00489	CcSEcCtD
Diflunisal—Renal failure—Etoposide—germ cell cancer	0.000792	0.00487	CcSEcCtD
Diflunisal—Jaundice—Etoposide—germ cell cancer	0.000786	0.00483	CcSEcCtD
Diflunisal—Stomatitis—Etoposide—germ cell cancer	0.000786	0.00483	CcSEcCtD
Diflunisal—Decreased appetite—Vinblastine—germ cell cancer	0.000784	0.00482	CcSEcCtD
Diflunisal—Constipation—Vinblastine—germ cell cancer	0.000771	0.00474	CcSEcCtD
Diflunisal—Confusional state—Bleomycin—germ cell cancer	0.000768	0.00472	CcSEcCtD
Diflunisal—Oedema—Bleomycin—germ cell cancer	0.000761	0.00469	CcSEcCtD
Diflunisal—Anaphylactic shock—Bleomycin—germ cell cancer	0.000761	0.00469	CcSEcCtD
Diflunisal—Visual impairment—Cisplatin—germ cell cancer	0.000761	0.00468	CcSEcCtD
Diflunisal—Agranulocytosis—Etoposide—germ cell cancer	0.000752	0.00463	CcSEcCtD
Diflunisal—Vision blurred—Ifosfamide—germ cell cancer	0.000751	0.00462	CcSEcCtD
Diflunisal—Thrombocytopenia—Bleomycin—germ cell cancer	0.000746	0.00459	CcSEcCtD
Diflunisal—Feeling abnormal—Vinblastine—germ cell cancer	0.000743	0.00457	CcSEcCtD
Diflunisal—PTGS1—uterus—germ cell cancer	0.000739	0.00547	CbGeAlD
Diflunisal—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000737	0.00454	CcSEcCtD
Diflunisal—Tinnitus—Cisplatin—germ cell cancer	0.000736	0.00453	CcSEcCtD
Diflunisal—Flushing—Cisplatin—germ cell cancer	0.000733	0.00451	CcSEcCtD
Diflunisal—Angioedema—Ifosfamide—germ cell cancer	0.000729	0.00448	CcSEcCtD
Diflunisal—PTGS1—pituitary gland—germ cell cancer	0.000726	0.00538	CbGeAlD
Diflunisal—Anorexia—Bleomycin—germ cell cancer	0.000726	0.00447	CcSEcCtD
Diflunisal—Vertigo—Ifosfamide—germ cell cancer	0.000716	0.00441	CcSEcCtD
Diflunisal—Photosensitivity—Methotrexate—germ cell cancer	0.000713	0.00439	CcSEcCtD
Diflunisal—Oedema—Dactinomycin—germ cell cancer	0.00071	0.00437	CcSEcCtD
Diflunisal—PTGS2—uterus—germ cell cancer	0.000707	0.00523	CbGeAlD
Diflunisal—ALB—brain—germ cell cancer	0.000706	0.00523	CbGeAlD
Diflunisal—Palpitations—Ifosfamide—germ cell cancer	0.000705	0.00434	CcSEcCtD
Diflunisal—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000695	0.00428	CcSEcCtD
Diflunisal—PTGS2—pituitary gland—germ cell cancer	0.000694	0.00514	CbGeAlD
Diflunisal—Erythema multiforme—Etoposide—germ cell cancer	0.000684	0.00421	CcSEcCtD
Diflunisal—Paraesthesia—Bleomycin—germ cell cancer	0.000684	0.00421	CcSEcCtD
Diflunisal—ALB—lymph node—germ cell cancer	0.000682	0.00505	CbGeAlD
Diflunisal—Dyspnoea—Bleomycin—germ cell cancer	0.000679	0.00418	CcSEcCtD
Diflunisal—Chest pain—Ifosfamide—germ cell cancer	0.000679	0.00418	CcSEcCtD
Diflunisal—Flatulence—Cisplatin—germ cell cancer	0.000677	0.00417	CcSEcCtD
Diflunisal—Anorexia—Dactinomycin—germ cell cancer	0.000677	0.00417	CcSEcCtD
Diflunisal—Flushing—Etoposide—germ cell cancer	0.000671	0.00413	CcSEcCtD
Diflunisal—PTGS2—medulla oblongata—germ cell cancer	0.00067	0.00496	CbGeAlD
Diflunisal—Hypersensitivity—Vinblastine—germ cell cancer	0.000664	0.00409	CcSEcCtD
Diflunisal—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000664	0.00408	CcSEcCtD
Diflunisal—Decreased appetite—Bleomycin—germ cell cancer	0.000662	0.00407	CcSEcCtD
Diflunisal—Visual disturbance—Methotrexate—germ cell cancer	0.000661	0.00407	CcSEcCtD
Diflunisal—Muscle spasms—Cisplatin—germ cell cancer	0.000661	0.00407	CcSEcCtD
Diflunisal—Confusional state—Ifosfamide—germ cell cancer	0.000656	0.00404	CcSEcCtD
Diflunisal—Oedema—Ifosfamide—germ cell cancer	0.000651	0.004	CcSEcCtD
Diflunisal—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000651	0.004	CcSEcCtD
Diflunisal—PTGS1—adrenal gland—germ cell cancer	0.000648	0.0048	CbGeAlD
Diflunisal—Vision blurred—Cisplatin—germ cell cancer	0.000648	0.00399	CcSEcCtD
Diflunisal—Asthenia—Vinblastine—germ cell cancer	0.000647	0.00398	CcSEcCtD
Diflunisal—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000637	0.00392	CcSEcCtD
Diflunisal—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000629	0.00387	CcSEcCtD
Diflunisal—Feeling abnormal—Bleomycin—germ cell cancer	0.000627	0.00386	CcSEcCtD
Diflunisal—PTGS1—spinal cord—germ cell cancer	0.000625	0.00463	CbGeAlD
Diflunisal—Anorexia—Ifosfamide—germ cell cancer	0.00062	0.00382	CcSEcCtD
Diflunisal—PTGS2—adrenal gland—germ cell cancer	0.00062	0.00459	CbGeAlD
Diflunisal—Decreased appetite—Dactinomycin—germ cell cancer	0.000617	0.0038	CcSEcCtD
Diflunisal—Diarrhoea—Vinblastine—germ cell cancer	0.000617	0.0038	CcSEcCtD
Diflunisal—Fatigue—Dactinomycin—germ cell cancer	0.000612	0.00377	CcSEcCtD
Diflunisal—PTGS2—midbrain—germ cell cancer	0.000612	0.00453	CbGeAlD
Diflunisal—Muscle spasms—Etoposide—germ cell cancer	0.000605	0.00373	CcSEcCtD
Diflunisal—Urticaria—Bleomycin—germ cell cancer	0.000605	0.00372	CcSEcCtD
Diflunisal—PTGS1—female gonad—germ cell cancer	0.000605	0.00448	CbGeAlD
Diflunisal—Body temperature increased—Bleomycin—germ cell cancer	0.000602	0.0037	CcSEcCtD
Diflunisal—PTGS2—bone marrow—germ cell cancer	0.0006	0.00444	CbGeAlD
Diflunisal—PTGS2—spinal cord—germ cell cancer	0.000597	0.00442	CbGeAlD
Diflunisal—Dizziness—Vinblastine—germ cell cancer	0.000596	0.00367	CcSEcCtD
Diflunisal—Feeling abnormal—Dactinomycin—germ cell cancer	0.000585	0.0036	CcSEcCtD
Diflunisal—Paraesthesia—Ifosfamide—germ cell cancer	0.000584	0.0036	CcSEcCtD
Diflunisal—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000581	0.00357	CcSEcCtD
Diflunisal—Dyspnoea—Ifosfamide—germ cell cancer	0.00058	0.00357	CcSEcCtD
Diflunisal—Somnolence—Ifosfamide—germ cell cancer	0.000579	0.00356	CcSEcCtD
Diflunisal—PTGS2—female gonad—germ cell cancer	0.000578	0.00428	CbGeAlD
Diflunisal—Vomiting—Vinblastine—germ cell cancer	0.000573	0.00353	CcSEcCtD
Diflunisal—Vertigo—Etoposide—germ cell cancer	0.000566	0.00348	CcSEcCtD
Diflunisal—Decreased appetite—Ifosfamide—germ cell cancer	0.000566	0.00348	CcSEcCtD
Diflunisal—Headache—Vinblastine—germ cell cancer	0.000565	0.00348	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000564	0.00347	CcSEcCtD
Diflunisal—PTGS1—endocrine gland—germ cell cancer	0.000562	0.00416	CbGeAlD
Diflunisal—Body temperature increased—Dactinomycin—germ cell cancer	0.000561	0.00345	CcSEcCtD
Diflunisal—Fatigue—Ifosfamide—germ cell cancer	0.000561	0.00345	CcSEcCtD
Diflunisal—Oedema—Cisplatin—germ cell cancer	0.000561	0.00345	CcSEcCtD
Diflunisal—Anaphylactic shock—Cisplatin—germ cell cancer	0.000561	0.00345	CcSEcCtD
Diflunisal—Hypersensitivity—Bleomycin—germ cell cancer	0.000561	0.00345	CcSEcCtD
Diflunisal—Constipation—Ifosfamide—germ cell cancer	0.000557	0.00342	CcSEcCtD
Diflunisal—PTGS1—head—germ cell cancer	0.000555	0.00411	CbGeAlD
Diflunisal—Loss of consciousness—Etoposide—germ cell cancer	0.000554	0.00341	CcSEcCtD
Diflunisal—Thrombocytopenia—Cisplatin—germ cell cancer	0.000549	0.00338	CcSEcCtD
Diflunisal—Asthenia—Bleomycin—germ cell cancer	0.000546	0.00336	CcSEcCtD
Diflunisal—Hyperhidrosis—Cisplatin—germ cell cancer	0.000542	0.00334	CcSEcCtD
Diflunisal—Pruritus—Bleomycin—germ cell cancer	0.000539	0.00331	CcSEcCtD
Diflunisal—PTGS2—endocrine gland—germ cell cancer	0.000537	0.00398	CbGeAlD
Diflunisal—Feeling abnormal—Ifosfamide—germ cell cancer	0.000536	0.0033	CcSEcCtD
Diflunisal—PTGS1—testis—germ cell cancer	0.000536	0.00397	CbGeAlD
Diflunisal—Chest pain—Etoposide—germ cell cancer	0.000536	0.0033	CcSEcCtD
Diflunisal—Nausea—Vinblastine—germ cell cancer	0.000536	0.0033	CcSEcCtD
Diflunisal—Anorexia—Cisplatin—germ cell cancer	0.000535	0.00329	CcSEcCtD
Diflunisal—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000532	0.00327	CcSEcCtD
Diflunisal—PTGS2—head—germ cell cancer	0.000531	0.00393	CbGeAlD
Diflunisal—Hypersensitivity—Dactinomycin—germ cell cancer	0.000523	0.00322	CcSEcCtD
Diflunisal—Confusional state—Etoposide—germ cell cancer	0.000518	0.00319	CcSEcCtD
Diflunisal—Urticaria—Ifosfamide—germ cell cancer	0.000517	0.00318	CcSEcCtD
Diflunisal—Body temperature increased—Ifosfamide—germ cell cancer	0.000514	0.00317	CcSEcCtD
Diflunisal—Anaphylactic shock—Etoposide—germ cell cancer	0.000514	0.00316	CcSEcCtD
Diflunisal—Asthenia—Dactinomycin—germ cell cancer	0.00051	0.00314	CcSEcCtD
Diflunisal—Dysuria—Methotrexate—germ cell cancer	0.000506	0.00311	CcSEcCtD
Diflunisal—Paraesthesia—Cisplatin—germ cell cancer	0.000504	0.0031	CcSEcCtD
Diflunisal—Thrombocytopenia—Etoposide—germ cell cancer	0.000503	0.0031	CcSEcCtD
Diflunisal—Dyspnoea—Cisplatin—germ cell cancer	0.0005	0.00308	CcSEcCtD
Diflunisal—Hyperhidrosis—Etoposide—germ cell cancer	0.000497	0.00306	CcSEcCtD
Diflunisal—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000494	0.00304	CcSEcCtD
Diflunisal—Anorexia—Etoposide—germ cell cancer	0.00049	0.00301	CcSEcCtD
Diflunisal—Decreased appetite—Cisplatin—germ cell cancer	0.000488	0.003	CcSEcCtD
Diflunisal—Diarrhoea—Dactinomycin—germ cell cancer	0.000486	0.00299	CcSEcCtD
Diflunisal—Vomiting—Bleomycin—germ cell cancer	0.000484	0.00298	CcSEcCtD
Diflunisal—Rash—Bleomycin—germ cell cancer	0.00048	0.00295	CcSEcCtD
Diflunisal—Dermatitis—Bleomycin—germ cell cancer	0.00048	0.00295	CcSEcCtD
Diflunisal—Hypersensitivity—Ifosfamide—germ cell cancer	0.000479	0.00295	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000479	0.00294	CcSEcCtD
Diflunisal—Renal failure—Methotrexate—germ cell cancer	0.000475	0.00292	CcSEcCtD
Diflunisal—PTGS2—cerebellum—germ cell cancer	0.000473	0.00351	CbGeAlD
Diflunisal—Stomatitis—Methotrexate—germ cell cancer	0.000471	0.0029	CcSEcCtD
Diflunisal—Asthenia—Ifosfamide—germ cell cancer	0.000467	0.00287	CcSEcCtD
Diflunisal—Sweating—Methotrexate—germ cell cancer	0.000463	0.00285	CcSEcCtD
Diflunisal—Feeling abnormal—Cisplatin—germ cell cancer	0.000462	0.00284	CcSEcCtD
Diflunisal—Paraesthesia—Etoposide—germ cell cancer	0.000462	0.00284	CcSEcCtD
Diflunisal—Pruritus—Ifosfamide—germ cell cancer	0.00046	0.00283	CcSEcCtD
Diflunisal—Haematuria—Methotrexate—germ cell cancer	0.00046	0.00283	CcSEcCtD
Diflunisal—Dyspnoea—Etoposide—germ cell cancer	0.000458	0.00282	CcSEcCtD
Diflunisal—Somnolence—Etoposide—germ cell cancer	0.000457	0.00281	CcSEcCtD
Diflunisal—Nausea—Bleomycin—germ cell cancer	0.000452	0.00278	CcSEcCtD
Diflunisal—Vomiting—Dactinomycin—germ cell cancer	0.000452	0.00278	CcSEcCtD
Diflunisal—Agranulocytosis—Methotrexate—germ cell cancer	0.00045	0.00277	CcSEcCtD
Diflunisal—Rash—Dactinomycin—germ cell cancer	0.000448	0.00276	CcSEcCtD
Diflunisal—Decreased appetite—Etoposide—germ cell cancer	0.000447	0.00275	CcSEcCtD
Diflunisal—Diarrhoea—Ifosfamide—germ cell cancer	0.000445	0.00274	CcSEcCtD
Diflunisal—Body temperature increased—Cisplatin—germ cell cancer	0.000444	0.00273	CcSEcCtD
Diflunisal—Fatigue—Etoposide—germ cell cancer	0.000443	0.00273	CcSEcCtD
Diflunisal—Constipation—Etoposide—germ cell cancer	0.00044	0.0027	CcSEcCtD
Diflunisal—Hepatitis—Methotrexate—germ cell cancer	0.000433	0.00267	CcSEcCtD
Diflunisal—Dizziness—Ifosfamide—germ cell cancer	0.00043	0.00265	CcSEcCtD
Diflunisal—Feeling abnormal—Etoposide—germ cell cancer	0.000424	0.00261	CcSEcCtD
Diflunisal—Nausea—Dactinomycin—germ cell cancer	0.000422	0.0026	CcSEcCtD
Diflunisal—Gastrointestinal pain—Etoposide—germ cell cancer	0.00042	0.00259	CcSEcCtD
Diflunisal—Visual impairment—Methotrexate—germ cell cancer	0.000418	0.00257	CcSEcCtD
Diflunisal—Vomiting—Ifosfamide—germ cell cancer	0.000414	0.00255	CcSEcCtD
Diflunisal—Hypersensitivity—Cisplatin—germ cell cancer	0.000413	0.00254	CcSEcCtD
Diflunisal—Rash—Ifosfamide—germ cell cancer	0.00041	0.00252	CcSEcCtD
Diflunisal—Dermatitis—Ifosfamide—germ cell cancer	0.00041	0.00252	CcSEcCtD
Diflunisal—Erythema multiforme—Methotrexate—germ cell cancer	0.00041	0.00252	CcSEcCtD
Diflunisal—Urticaria—Etoposide—germ cell cancer	0.000408	0.00251	CcSEcCtD
Diflunisal—Body temperature increased—Etoposide—germ cell cancer	0.000406	0.0025	CcSEcCtD
Diflunisal—Tinnitus—Methotrexate—germ cell cancer	0.000404	0.00249	CcSEcCtD
Diflunisal—Asthenia—Cisplatin—germ cell cancer	0.000403	0.00248	CcSEcCtD
Diflunisal—PTGS1—brain—germ cell cancer	0.000402	0.00298	CbGeAlD
Diflunisal—PTGS1—lymph node—germ cell cancer	0.000389	0.00288	CbGeAlD
Diflunisal—Nausea—Ifosfamide—germ cell cancer	0.000387	0.00238	CcSEcCtD
Diflunisal—PTGS2—brain—germ cell cancer	0.000385	0.00285	CbGeAlD
Diflunisal—Diarrhoea—Cisplatin—germ cell cancer	0.000384	0.00236	CcSEcCtD
Diflunisal—Hypersensitivity—Etoposide—germ cell cancer	0.000379	0.00233	CcSEcCtD
Diflunisal—PTGS2—lymph node—germ cell cancer	0.000372	0.00275	CbGeAlD
Diflunisal—Asthenia—Etoposide—germ cell cancer	0.000369	0.00227	CcSEcCtD
Diflunisal—Pruritus—Etoposide—germ cell cancer	0.000364	0.00224	CcSEcCtD
Diflunisal—Vomiting—Cisplatin—germ cell cancer	0.000357	0.00219	CcSEcCtD
Diflunisal—Vision blurred—Methotrexate—germ cell cancer	0.000356	0.00219	CcSEcCtD
Diflunisal—Rash—Cisplatin—germ cell cancer	0.000354	0.00218	CcSEcCtD
Diflunisal—Dermatitis—Cisplatin—germ cell cancer	0.000353	0.00217	CcSEcCtD
Diflunisal—Diarrhoea—Etoposide—germ cell cancer	0.000352	0.00216	CcSEcCtD
Diflunisal—Dizziness—Etoposide—germ cell cancer	0.00034	0.00209	CcSEcCtD
Diflunisal—Vertigo—Methotrexate—germ cell cancer	0.000339	0.00209	CcSEcCtD
Diflunisal—Nausea—Cisplatin—germ cell cancer	0.000333	0.00205	CcSEcCtD
Diflunisal—Vomiting—Etoposide—germ cell cancer	0.000327	0.00201	CcSEcCtD
Diflunisal—Rash—Etoposide—germ cell cancer	0.000324	0.00199	CcSEcCtD
Diflunisal—Dermatitis—Etoposide—germ cell cancer	0.000324	0.00199	CcSEcCtD
Diflunisal—Headache—Etoposide—germ cell cancer	0.000322	0.00198	CcSEcCtD
Diflunisal—Chest pain—Methotrexate—germ cell cancer	0.000321	0.00198	CcSEcCtD
Diflunisal—Confusional state—Methotrexate—germ cell cancer	0.00031	0.00191	CcSEcCtD
Diflunisal—Anaphylactic shock—Methotrexate—germ cell cancer	0.000308	0.00189	CcSEcCtD
Diflunisal—Nausea—Etoposide—germ cell cancer	0.000305	0.00188	CcSEcCtD
Diflunisal—Thrombocytopenia—Methotrexate—germ cell cancer	0.000301	0.00185	CcSEcCtD
Diflunisal—Hyperhidrosis—Methotrexate—germ cell cancer	0.000298	0.00183	CcSEcCtD
Diflunisal—Anorexia—Methotrexate—germ cell cancer	0.000293	0.00181	CcSEcCtD
Diflunisal—Insomnia—Methotrexate—germ cell cancer	0.000278	0.00171	CcSEcCtD
Diflunisal—Paraesthesia—Methotrexate—germ cell cancer	0.000276	0.0017	CcSEcCtD
Diflunisal—Dyspnoea—Methotrexate—germ cell cancer	0.000274	0.00169	CcSEcCtD
Diflunisal—Somnolence—Methotrexate—germ cell cancer	0.000274	0.00168	CcSEcCtD
Diflunisal—Dyspepsia—Methotrexate—germ cell cancer	0.000271	0.00167	CcSEcCtD
Diflunisal—Decreased appetite—Methotrexate—germ cell cancer	0.000268	0.00165	CcSEcCtD
Diflunisal—Fatigue—Methotrexate—germ cell cancer	0.000265	0.00163	CcSEcCtD
Diflunisal—Feeling abnormal—Methotrexate—germ cell cancer	0.000254	0.00156	CcSEcCtD
Diflunisal—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000252	0.00155	CcSEcCtD
Diflunisal—Urticaria—Methotrexate—germ cell cancer	0.000245	0.0015	CcSEcCtD
Diflunisal—Body temperature increased—Methotrexate—germ cell cancer	0.000243	0.0015	CcSEcCtD
Diflunisal—Hypersensitivity—Methotrexate—germ cell cancer	0.000227	0.0014	CcSEcCtD
Diflunisal—Asthenia—Methotrexate—germ cell cancer	0.000221	0.00136	CcSEcCtD
Diflunisal—Pruritus—Methotrexate—germ cell cancer	0.000218	0.00134	CcSEcCtD
Diflunisal—Diarrhoea—Methotrexate—germ cell cancer	0.000211	0.0013	CcSEcCtD
Diflunisal—Dizziness—Methotrexate—germ cell cancer	0.000204	0.00125	CcSEcCtD
Diflunisal—Vomiting—Methotrexate—germ cell cancer	0.000196	0.0012	CcSEcCtD
Diflunisal—Rash—Methotrexate—germ cell cancer	0.000194	0.00119	CcSEcCtD
Diflunisal—Dermatitis—Methotrexate—germ cell cancer	0.000194	0.00119	CcSEcCtD
Diflunisal—Headache—Methotrexate—germ cell cancer	0.000193	0.00119	CcSEcCtD
Diflunisal—Nausea—Methotrexate—germ cell cancer	0.000183	0.00113	CcSEcCtD
